Polymerase Chain Reaction (PCR) is a technique that is used for exponential amplification of DNA fragments in vitro. PCR is used in life science research labs for a variety of applications such as disease diagnosis (leukemia, lymphoma, and infectious diseases), selective DNA isolation and amplification, and quantification of DNA.
Asia accounted for 24.2% market share of the polymerase chain reaction market globally in 2013. The market valued at $1046 million in 2012 and is expected to grow at a CAGR of 20.3% from 2013 to 2018.
The increased laboratory usage of PCR in proteomics and genomics, automation of instruments, and advanced technologies like qRT-PCR are factors that are boosting the growth of the PCR market. The qRT-PCR technology is highly cost effective and involves concurrent monitoring of expression levels of multiple genetic messages in real time.
This market is segmented and forecasted on the basis of different types, namely: PCR instruments, PCR reagents, PCR consumables, RT-PCR, and Thermal cycler PCR. RT-PCR accounts for the largest share of Asia PCR market and is expected to grow at a CAGR of 16% from 2013 to 2018. On the basis of applications the market is segmented into In Vitro diagnostics, Drug discovery, Academics, Agrigenomics, and Personalized medicine. The market is further segmented and forecasted on the basis of major countries, such as India, China, and Japan.
The report provides an extensive competitive landscaping of companies operating in this market. The key players of the market covered in the report are Life Technologies, Bio-Rad Laboratories, Inc., Agilent Technologies, Roche Diagnostics, Bioline, Eppendorf AG, and Thermo Fisher Scientific. This report also includes the market share, value chain analysis, and market metrics such as drivers, restraints and upcoming opportunities.
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement